TB006
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for TB006, covering 2023-11-18 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease [Phase 2]